Hologic Price To Operating Cash Flows Ratio from 2010 to 2025

HOLX Stock  USD 65.23  0.22  0.34%   
Hologic Price To Operating Cash Flows Ratio yearly trend continues to be fairly stable with very little volatility. Price To Operating Cash Flows Ratio will likely drop to 15.48 in 2025. During the period from 2010 to 2025, Hologic Price To Operating Cash Flows Ratio regression line of annual values had r-squared of  0.06 and arithmetic mean of  12.53. View All Fundamentals
 
Price To Operating Cash Flows Ratio  
First Reported
2010-12-31
Previous Quarter
16.29183486
Current Value
15.48
Quarterly Volatility
4.99759948
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Hologic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hologic's main balance sheet or income statement drivers, such as Depreciation And Amortization of 373.1 M, Interest Expense of 74.8 M or Total Revenue of 4.9 B, as well as many indicators such as Price To Sales Ratio of 2.14, Dividend Yield of 0.0 or PTB Ratio of 3.24. Hologic financial statements analysis is a perfect complement when working with Hologic Valuation or Volatility modules.
  
Check out the analysis of Hologic Correlation against competitors.
For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.

Latest Hologic's Price To Operating Cash Flows Ratio Growth Pattern

Below is the plot of the Price To Operating Cash Flows Ratio of Hologic over the last few years. It is Hologic's Price To Operating Cash Flows Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hologic's overall financial position and show how it may be relating to other accounts over time.
Price To Operating Cash Flows Ratio10 Years Trend
Pretty Stable
   Price To Operating Cash Flows Ratio   
       Timeline  

Hologic Price To Operating Cash Flows Ratio Regression Statistics

Arithmetic Mean12.53
Geometric Mean11.67
Coefficient Of Variation39.88
Mean Deviation3.81
Median13.69
Standard Deviation5.00
Sample Variance24.98
Range18.4894
R-Value(0.25)
Mean Square Error25.15
R-Squared0.06
Significance0.36
Slope(0.26)
Total Sum of Squares374.64

Hologic Price To Operating Cash Flows Ratio History

2025 15.48
2024 16.29
2022 14.82
2016 7.45
2011 13.69
2010 25.94

About Hologic Financial Statements

Hologic investors use historical fundamental indicators, such as Hologic's Price To Operating Cash Flows Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Hologic. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Operating Cash Flows Ratio 16.29  15.48 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Hologic Stock Analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.